Please use this identifier to cite or link to this item: http://ir.mu.ac.ke:8080/jspui/handle/123456789/6809
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVreeman, Rachel C-
dc.contributor.authorRakhmanina, Natella Y-
dc.contributor.authorNyandiko, Winstone M-
dc.contributor.authorPuthanakit, Thanyawee-
dc.contributor.authorKantor, Rami-
dc.date.accessioned2022-09-28T12:34:47Z-
dc.date.available2022-09-28T12:34:47Z-
dc.date.issued2021-06-07-
dc.identifier.uridoi.org/10.1002/jia2.25759-
dc.identifier.urihttp://ir.mu.ac.ke:8080/jspui/handle/123456789/6809-
dc.description.abstractForty years ago, the first adult HIV cases were published, with infant cases following within a year [1]. As a few of these then‐babies approach their 40th birthdays, both their growth and science’s growth tell dramatic stories. Antiretroviral therapy (ART) transformed HIV from a deadly infection into a chronic disease. Just as miraculous, an AIDS‐free generation became imaginable, using ART to prevent >95% of perinatal transmission. While these advances in HIV prevention and treatment deserve celebration, attention should be devoted to remaining hurdles – such as behavioural, social viral suppression and drug resistance challenges – that must still be overcome to ensure successful life‐long outcomes for the global population of children and adolescents who have grown up with HIV (CAWH)en_US
dc.description.sponsorshipNIH R01 AI147333 and R01 AI120792en_US
dc.language.isoenen_US
dc.publisherPubMed Centralen_US
dc.subjectAdult HIVen_US
dc.subject40 years of successes and challengesen_US
dc.titleAre we there yet? 40 years of successes and challenges for children and adolescents living with HIVen_US
dc.typeArticleen_US
Appears in Collections:School of Medicine

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.